Mini-organs for toxicity testing


Researchers at EARA member Wageningen University & Research, Netherlands, have developed mini-organs for testing new medicines, reducing the need for animal testing.


Although organ-on-a-chip technology is growing in popularity and is more widely used in other areas of biomedical research, its use in toxicity testing for drugs is currently limited.


Current 2D cell-based models for toxicity testing cannot reflect the complexity of a whole organ, and so, in partnership with Unilever, the team aimed to produce 3D mini-organs which included a number of different cell types and structures, that more closely resemble the human body.


“We want to show that our mini-organs, combined with computer modelling, can provide an adequate simulation of human tissue functions and biological reactions to chemicals,” says Dr Hans Bouwmeester of the Wageningen Toxicology department.

Recent Posts

See All